factually
Index/Topics/Metformin Repurposing Trial

Metformin Repurposing Trial

Metformin repurposing trial for Alzheimer's disease expected to complete in April 2026

Fact-Checks

2 results
Jan 15, 2026
Most Viewed

Which Phase III Alzheimer's drug trials are expected to report results in 2026 and what mechanisms do they target?

The Alzheimer’s field is poised for multiple high‑profile Phase III and confirmatory readouts in 2026, with programs ranging from next‑generation anti‑amyloid antibodies to oral small molecules and me...

Feb 6, 2026

Which Alzheimer’s treatments are in phase 3 trials with potential 2026 readouts and who are the funders?

Several high‑profile Phase 3 Alzheimer’s trials could report results in 2026, including ’s anti‑amyloid , ’s EVOKE program, ’s pivotal study, the POLARIS‑AD trial of AR1001, and a phase 3 trial; fundi...